Corvus Pharmaceuticals Inc (CRVS)
Healthcare
Biotechnology
13.40 $
+0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Corvus Pharmaceuticals Inc (CRVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.1 | -11 | -28 | -46 | -41 | -37 | -35 | -37 | -27 | -24 | -25 | -33 | |
| 0.1 | 0.1 | 0.6 | 0.8 | 0.8 | 0.7 | 0.6 | 0.5 | 0.4 | 0.2 | 0.1 | 0.1 | |
| – | 0.4 | 3.8 | 6.2 | 7.1 | 7.3 | 5.7 | 4.2 | 2.7 | 2.1 | 3.0 | 5.3 | |
| 18 | 18 | 4.5 | 6.0 | 7.1 | 7.3 | -31 | 9.3 | – | – | – | – | |
| 0.0 | 1.8 | 3.4 | 2.6 | -1.4 | 1.9 | 1.9 | -3.2 | 1.4 | -3.6 | -1.6 | 3.6 | |
| 1.7 | 1.7 | 2.2 | 0.3 | 0.4 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 | 0.0 | 0.2 | |
| -92 | -92 | -43 | 85 | -30 | 3.3 | 45 | 22 | -23 | 16 | -27 | -7.8 | |
| – | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 96 | 71 | 1.4 | 65 | 0.0 | 1.3 | – | – | – | – | – | |
| 14 | 95 | 71 | 1.4 | 65 | 0.0 | 1.3 | 62 | 0.0 | 7.9 | 49 | 36 | |
| 14 | -8.4 | 0.9 | 40 | -5.9 | -34 | 11 | 47 | -50 | -0.5 | -3.9 | -4.2 | |
| -0.1 | -13 | -30 | -46 | -41 | -37 | -35 | -37 | -27 | -24 | -25 | -33 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.